The PE Ratio as of December 2024 (TTM) for Alpine Immune Sciences, Inc. (ALPN) is -101.52

According to Alpine Immune Sciences, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -101.52. This represents a change of 4.37% compared to the average of -2.27 of the last 4 quarters.

Alpine Immune Sciences, Inc. (ALPN) Historical PE Ratio (quarterly & annually)

How has ALPN PE Ratio performed in the past?

The mean historical PE Ratio of Alpine Immune Sciences, Inc. over the last ten years is -7.60. The current -101.52 PE Ratio has changed 133.50% with respect to the historical average. Over the past ten years (40 quarters), ALPN's PE Ratio was at its highest in in the December 2023 quarter at 48.25. The PE Ratio was at its lowest in in the March 2024 quarter at -35.93.

Alpine Immune Sciences, Inc. (ALPN) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Alpine Immune Sciences, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Alpine Immune Sciences, Inc. (ALPN) Average PE Ratio

How has ALPN PE Ratio performed in the past?

The current PE Ratio of Alpine Immune Sciences, Inc. (ALPN) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Alpine Immune Sciences, Inc. (ALPN) PE Ratio vs. Peers

How is ALPN’s PE Ratio compared to its peers?

Alpine Immune Sciences, Inc.’s PE Ratio is less than Terns Pharmaceuticals, Inc. (0), less than Day One Biopharmaceuticals, Inc. (-5.12), less than Acumen Pharmaceuticals, Inc. (-14.52), less than Amylyx Pharmaceuticals, Inc. (-1.32), less than MoonLake Immunotherapeutics (-1.05), less than Anebulo Pharmaceuticals, Inc. (-41.02), less than Adagene Inc. (-5.30), less than Acrivon Therapeutics, Inc. Common Stock (-2.67), less than AnaptysBio, Inc. (-3.08), less than Mineralys Therapeutics, Inc. (-2.42), less than Tenaya Therapeutics, Inc. (-4.16), less than Bicycle Therapeutics plc (-1.22), less than IGM Biosciences, Inc. (-6.09), less than Monte Rosa Therapeutics, Inc. (-1.77), less than Stoke Therapeutics, Inc. (-4.84), less than null (-6.05),

Build a custom stock screener for Alpine Immune Sciences, Inc. (ALPN) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Alpine Immune Sciences, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Alpine Immune Sciences, Inc. (ALPN) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Alpine Immune Sciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.